If any of the specialist agencies involved in the procedure (Art. 37 para. 1) comes into possession of new findings on the risks posed by the experimental release after issue of authorisation, it shall inform the FOEN.
In the case of information in accordance with paragraph 1 and Article 23, the FOEN shall, with the consent of the federal agencies involved in the procedure, prescribe appropriate measures. In particular, it may require that:
the risk determination and assessment (Art. 19 para. 2 let. d, 20 para. 2 let. d, or 21 para. 2 let. d) be carried out again;
the conditions of the experimental release be changed;
the experimental release be interrupted or if necessary terminated and, as far as possible, the original conditions restored.
It shall consult the SECB and the ECNH.